# Ochre Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ochre-bio

- Industry: Biotechnology
- Headquarters: Oxford, UK
- Website: www.ochre-bio.com
- Total disclosed funding: $40M
- Latest round: Series A (Oct 10, 2022)
- Investors on record: 11

## About

Founded in 2019 and based in Oxford, UK, Ochre Bio Limited operates as a developer of AI-integrated drug development procedure for genomic medicines called deep phenotyping that helps in shutting down over-active genes for livers before transplant. The company was founded by the CEO Jack O'meara and Quin Wills. In June 2021, the company received its first seed funding from a group of investors that includes Khosla Ventures, Backed VC, and Appolo Health Ventures.

The company's product is focusing on developing a genomic medicine that uses an AI-integrated drug development procedure called deep phenotyping. The medicine focuses on shutting down the over-active genes that cause chronic liver diseases. The formula specifically targets the liver that will undergo transplants or under medication.

The company's revenue is generated by the sales of its RNA medicines to its target market mostly patients that will undergo transplants and under medications.

The company plans to expand its platform to identify and validate new liver targets.

## Funding rounds

- Series A, Oct 10, 2022, $30M — Khosla Ventures, Backed VC, Gaingels, EIT Digital, Hermes Epitek Corp., LifeForce Capital, Selvedge Venture, Lifelink Systems, Inc., AixThera
- Seed, Jun 16, 2021, $9.6M — Khosla Ventures, Hoxton Ventures, Backed VC, Hermes Epitek Corp., Apollo Health Ventures, Selvedge Venture

## Investors

- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Seed, Series A
- Hoxton Ventures (https://capitalatlas.ai/funds/hoxton-ventures) — Seed
- Backed VC (https://capitalatlas.ai/funds/backed-vc) — Seed, Series A
- Hermes Epitek Corp. — Seed, Series A
- Apollo Health Ventures (https://capitalatlas.ai/funds/apollo-health-ventures) — Seed
- Selvedge Venture (https://capitalatlas.ai/funds/selvedge-venture) — Seed, Series A
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Series A
- EIT Digital — Series A
- LifeForce Capital (https://capitalatlas.ai/funds/lifeforce-capital) — Series A
- Lifelink Systems, Inc. — Series A
- AixThera — Series A